Acupuncture for Primary Sjögren Syndrome
Primary Purpose
Sjogren's Syndrome
Status
Unknown status
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
acupuncture group
Sham Acupuncture group
Sponsored by

About this trial
This is an interventional treatment trial for Sjogren's Syndrome
Eligibility Criteria
Inclusion Criteria:
- To fulfill the American-European Consensus Group Criteria for primary Sjögren syndrome.
- With the symptoms of primary Sjögren syndrome less than 5 years.
Exclusion Criteria:
- With an acupuncture contraindication (allergy to metals, skin lesions on relative acupoints, etc.)
- Taking or taken medicine for primary Sjögren syndrome within last 4 weeks before the enrollment.
Sites / Locations
- Guang'anmen Hospital, China academy of Chinese Medical Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Acupuncture group
Sham Acupuncture group
Arm Description
Participants will receive acupuncture for 8 weeks. In particular, acupuncture will be performed three times a week in earlier 4 weeks and twice a week in later 4 weeks.
Participants will receive sham acupuncture for 8 weeks. The procedure is the same as the acupuncture arm.
Outcomes
Primary Outcome Measures
The proportion of participants who has a 30% or greater reduction in 2 of 3 items,including the numeric analog scale (NAS) of dryness, fatigue, and pain.
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
Secondary Outcome Measures
Change in NAS of each item including dryness, fatigue, and pain.
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
Change in EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
it will be measured at week0/8/16/24
Change in Medical Outcome Study Short Form 36 Short-Form Health Survey (SF-36)
it will be measured at week0/8/16/24
Change in Hospital Anxiety and Depression (HAD) scale score
it will be measured at week0/8/16/24
Change in serum Immunoglobulin G (IgG),immunoglobulin A (IgA), and immunoglobulin M (IgM) levels
it will be measured at week0/24
Change in image of Salivary glands measured by ultrasound
it will be measured at week0/24
Change in Schirmer test score and unstimulated salivary flow
it will be measured at week0/8/16/24
Adverse events
it will be measured at week0/8/16/24, and be observed, documented, and evaluated in detail.
Full Information
NCT ID
NCT02691377
First Posted
February 20, 2016
Last Updated
February 26, 2016
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT02691377
Brief Title
Acupuncture for Primary Sjögren Syndrome
Official Title
Efficacy and Safety of Acupuncture for Primary Sjögren Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Unknown status
Study Start Date
March 2016 (undefined)
Primary Completion Date
March 2017 (Anticipated)
Study Completion Date
March 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether acupuncture is effective and safe in the treatment of Primary Sjögren Syndrome.
Detailed Description
This randomized, double-blinded, sham acupuncture controlled trial is aimed to assess the effectiveness and safety of acupuncture in the treatment of Primary Sjögren Syndrome.The eligible participants will be randomly allocated to receive acupuncture or sham acupuncture for 8 weeks.
Assuming a two-sided alpha of 0.05, power of 85%, and a 20% drop-out, a sample sized of 30 would be needed for each group. The statistical analysis will be based on the intention-to-treat principle. Continuous variables will be compared by Student t test or Mann-Whitney U test; categorical variables will be analyzed by chi-square test, Fisher's exact test or Kruskal-Wallis H test as appropriate. For comparison between two time points, paired t-test or Wilcoxon signed rank test will be used as appropriate. A statistically significant difference was set at P<0.05.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sjogren's Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Acupuncture group
Arm Type
Experimental
Arm Description
Participants will receive acupuncture for 8 weeks. In particular, acupuncture will be performed three times a week in earlier 4 weeks and twice a week in later 4 weeks.
Arm Title
Sham Acupuncture group
Arm Type
Sham Comparator
Arm Description
Participants will receive sham acupuncture for 8 weeks. The procedure is the same as the acupuncture arm.
Intervention Type
Device
Intervention Name(s)
acupuncture group
Intervention Description
Acupoints include 11 on the head, two on the upper extremities, and two on the lower extremities. Before performing acupuncture, a small pad will be pasted on each acupoint. All the needles will insert the acupoints through these pads. Then, they will be twirled, lifted and thrust three times to elicit the Deqi sensation. Each session will last 30 minutes.
Intervention Type
Device
Intervention Name(s)
Sham Acupuncture group
Intervention Description
The same acupoints with acupuncture group are selected.A placebo needle with a blunt tip will be used to perform sham acupuncture. They will only insert the pad and no skin penetration. The same procedure with acupuncture group will be performed.
Primary Outcome Measure Information:
Title
The proportion of participants who has a 30% or greater reduction in 2 of 3 items,including the numeric analog scale (NAS) of dryness, fatigue, and pain.
Description
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Change in NAS of each item including dryness, fatigue, and pain.
Description
Subjects will be asked to provide every NAS score based on the average situation over the past 24 hours 13 rather than a point of time. And we will collect NAS scores three times a week in week0-8 (24 times in total) as removal of a variety of factors causing bias, including mental relaxation in weekend, weather changing, or unexpected events life in, etc., each of which may influence the feelings of dryness, fatigue, and pain.
Time Frame
24 weeks
Title
Change in EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
Description
it will be measured at week0/8/16/24
Time Frame
24 weeks
Title
Change in Medical Outcome Study Short Form 36 Short-Form Health Survey (SF-36)
Description
it will be measured at week0/8/16/24
Time Frame
24 weeks
Title
Change in Hospital Anxiety and Depression (HAD) scale score
Description
it will be measured at week0/8/16/24
Time Frame
24 weeks
Title
Change in serum Immunoglobulin G (IgG),immunoglobulin A (IgA), and immunoglobulin M (IgM) levels
Description
it will be measured at week0/24
Time Frame
24 weeks
Title
Change in image of Salivary glands measured by ultrasound
Description
it will be measured at week0/24
Time Frame
24 weeks
Title
Change in Schirmer test score and unstimulated salivary flow
Description
it will be measured at week0/8/16/24
Time Frame
24 weeks
Title
Adverse events
Description
it will be measured at week0/8/16/24, and be observed, documented, and evaluated in detail.
Time Frame
24 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
To fulfill the American-European Consensus Group Criteria for primary Sjögren syndrome.
With the symptoms of primary Sjögren syndrome less than 5 years.
Exclusion Criteria:
With an acupuncture contraindication (allergy to metals, skin lesions on relative acupoints, etc.)
Taking or taken medicine for primary Sjögren syndrome within last 4 weeks before the enrollment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xinyao Zhou, MD
Phone
+8610-88001030
Email
xyz_1102@126.com
First Name & Middle Initial & Last Name or Official Title & Degree
Ran Pang, MD
Phone
+8610-88001040
Email
pangran2002@sina.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xinyao Zhou, MD
Organizational Affiliation
Guang'anmen Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Guang'anmen Hospital, China academy of Chinese Medical Sciences
City
Beijing
ZIP/Postal Code
100053
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xinyao Zhou, MD
Phone
+8610-88001030
Email
xyz_1102@126.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
35602489
Citation
Zhou X, Xu H, Chen J, Wu H, Zhang Y, Tian F, Tang X, Zhang H, Ge L, Li K, Jiang W, Liu Z, Jiang Q. Efficacy and Safety of Acupuncture on Symptomatic Improvement in Primary Sjogren's Syndrome: A Randomized Controlled Trial. Front Med (Lausanne). 2022 May 6;9:878218. doi: 10.3389/fmed.2022.878218. eCollection 2022.
Results Reference
derived
PubMed Identifier
28103850
Citation
Jiang Q, Zhang H, Pang R, Chen J, Liu Z, Zhou X. Acupuncture for Primary Sjogren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial. BMC Complement Altern Med. 2017 Jan 19;17(1):61. doi: 10.1186/s12906-017-1559-9.
Results Reference
derived
Learn more about this trial
Acupuncture for Primary Sjögren Syndrome
We'll reach out to this number within 24 hrs